Cargando…

Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literature

We report successful clinical experience using anti-BCMA CAR-T combined with lenalidomide in a patient who was refractory to a previous CAR-T treatment. The patient was a 51-year-old man, and was diagnosed with IgD-λ multiple myeloma(MM) in October 2015. 10 courses of chemotherapy including immunomo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Guoxing, Wei, Runhong, Feng, Lei, Wu, Yi, He, Feng, Xiao, Mingxing, Cheng, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8738460/
https://www.ncbi.nlm.nih.gov/pubmed/34003300
http://dx.doi.org/10.1007/s00262-021-02959-8